Searchlight
Summary
Montreal-based Searchlight Pharma continues its growth plan based on the acquisition, commercialization, and development of unique healthcare products.Founded in 2015, Searchlight Pharma has rapidly evolved into one of the fastest growing specialty pharmaceutical companies in Canada, having concluded 9 transactions that have contributed 15 marketed products in Canada and additional pipeline candidates that are expected to launch over the next 12-18 months. Searchlight Pharmas flagship branded prescription products include Estragyn Vaginal Cream for the treatment of vulvovaginal atrophy and the family of Mona Lisa\xae intrauterine devices ( s) which are indicated for non-hormonal contraception. "Both of these investors have extensive experience in life sciences, and understand what is required for companies like Searchlight to succeed in todays competitive environment. Given the pace and scope of our business development activities, access to the deep financial resources and support of these two partners is extremely valuable and provides Searchlight Pharma with the means to achieve its growth ambitions. Alongside this investment, we aim to dedicate our financial and network resources to enable the company to accelerate both its organic and acquisition growth.